Skip to content

Drug interactions

Apalutamide + Ledipasvir-sofosbuvir

Severity: Major

Apalutamide and Ledipasvir-sofosbuvir: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Apalutamide is an inducer of several enzymes and transporters, including P-gp and BCRP. It may lower exposure to ledipasvir and sofosbuvir, which are P-gp and BCRP substrates, and risk reduced antiviral efficacy.

What this interaction means in plain words

Apalutamide and Ledipasvir-sofosbuvir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Apalutamide belongs to Endocrine; Ledipasvir-sofosbuvir belongs to Anti Virals.

Evidence level: Low

Why it happens

Apalutamide induces P-gp and BCRP, increasing efflux and reducing absorption of ledipasvir and sofosbuvir.

What to do

Avoid the combination where possible, since reduced antiviral exposure may compromise cure. If unavoidable, monitor HCV viral response closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apalutamide and Ledipasvir-sofosbuvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Apalutamide with Ledipasvir-sofosbuvir?

MediHelp rates the interaction as major. Apalutamide and Ledipasvir-sofosbuvir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Apalutamide is an inducer of several enzymes and transporters, including P-gp and BCRP. It may lower exposure to ledipasvir and sofosbuvir, which are P-gp and BCRP substrates, and risk reduced antiviral efficacy.

How serious is the interaction between Apalutamide and Ledipasvir-sofosbuvir?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible, since reduced antiviral exposure may compromise cure. If unavoidable, monitor HCV viral response closely.

What other medicines interact with Ledipasvir-sofosbuvir?

MediHelp also lists interactions of Ledipasvir-sofosbuvir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Ledipasvir-sofosbuvir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in